|
|
| Line 1: |
Line 1: |
| [[Image:2p4j.gif|left|200px]] | | {{Seed}} |
| | [[Image:2p4j.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
| Line 9: |
Line 10: |
| {{STRUCTURE_2p4j| PDB=2p4j | SCENE= }} | | {{STRUCTURE_2p4j| PDB=2p4j | SCENE= }} |
|
| |
|
| '''Crystal structure of beta-secretase bond to an inhibitor with Isophthalamide Derivatives at P2-P3'''
| | ===Crystal structure of beta-secretase bond to an inhibitor with Isophthalamide Derivatives at P2-P3=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| Structure-based design and synthesis of a number of potent and selective memapsin 2 inhibitors are described. These inhibitors were designed based upon the X-ray structure of memapsin 2-bound inhibitor 3 that incorporates methylsulfonyl alanine as the P2-ligand and a substituted pyrazole as the P3-ligand. Of particular importance, we examined the ability of the substituted isophthalic acid amide derivative to mimic the key interactions in the S2-S3 regions of the enzyme active sites of 3-bound memapsin 2. We investigated various substituted phenylethyl, alpha-methylbenzyl, and oxazolylmethyl groups as the P3-ligands. A number of inhibitors exhibited very potent inhibitory activity against mempasin 2 and good selectivity against memapsin 1. Inhibitor 5d has shown low nanomolar enzyme inhibitory potency (Ki=1.1 nM) and very good cellular inhibitory activity (IC50=39 nM). Furthermore, in a preliminary study, inhibitor 5d has shown 30% reduction of Abeta40 production in transgenic mice after a single intraperitoneal administration (8 mg/kg). A protein-ligand X-ray crystal structure of 5d-bound memapsin 2 provided vital molecular insight that can serve as an important guide to further design of novel inhibitors.
| | The line below this paragraph, {{ABSTRACT_PUBMED_17432843}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 17432843 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_17432843}} |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
| Line 35: |
Line 39: |
| [[Category: Memapsin]] | | [[Category: Memapsin]] |
| [[Category: Structure based drug design]] | | [[Category: Structure based drug design]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 12:20:40 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 19:25:56 2008'' |